Citi Places WUXI APPTEC (02359) on 90-Day Positive Catalyst Watch with HK$142 Target

Stock News01-14

Citi has released a research report placing WUXI APPTEC (02359) on a 90-day positive catalyst watch, noting that the group is scheduled to participate in and deliver a presentation at a US healthcare conference this Wednesday, the 14th, Pacific Time. Based on a recovery in global financing, Citi anticipates that WUXI APPTEC's management will maintain an optimistic outlook for the current year and provide clearer 2026 performance guidance and details during its March earnings report. The bank considers WUXI APPTEC's valuation attractive, assigning it a "Buy" rating with a target price of HK$142. Citi expects the company's robust growth prospects to be supported by increasing order volumes from both domestic and international sources, projecting that its China-based laboratory business, bolstered by its "long-tail" strategy and differentiated services from innovative platforms, achieved a sales compound annual growth rate of 27.4% from 2020 to 2023.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap
Leave a comment